36 / 61
Key Secondary Endpoint, Pre-specified Hierarchical Analysis
LUME-Lung 1: OS in Patients with Adenocarcinoma who
Progressed in <9 Months After Start of First-Line Therapy
|
|
36 / 61
36 / 61
Key Secondary Endpoint, Pre-specified Hierarchical Analysis
LUME-Lung 1: OS in Patients with Adenocarcinoma who
Progressed in <9 Months After Start of First-Line Therapy